The study design and results of a Phase 1 clinical trial investigating PTC596 in a range of solid tumors are presented in our poster at the 2016 EORTC-NCI-AACR Symposium in Munich
EORTC-NCI-AACR Symposium 2016 poster: Preliminary Phase 1 results of PTC596, a novel small molecule targeting cancer stem cells (CSCs) by reducing levels of BMI1 protein
GL-CORP-0207 | June 2021
The content you are trying to access is not currently available.
We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.